Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer.
Robert ColemanYing ZhouDanielle JandialBenoit CadieuxArlene ChanPublished in: Advances in therapy (2021)
NCT01077154.
Keyphrases
- double blind
- placebo controlled
- early breast cancer
- bone mineral density
- phase iii
- clinical trial
- phase ii
- healthcare
- early stage
- open label
- palliative care
- study protocol
- quality improvement
- phase ii study
- postmenopausal women
- pain management
- body composition
- cross sectional
- bone loss
- bone regeneration
- locally advanced
- affordable care act